Frequentist evaluation of group sequential clinical trial designs

Statistics in Medicine

Volumn 26, Issue 28, 2007, Pages 5047-5080

  Emerson, Scott S ^a   Kittelson, John M ^b   Gillen, Daniel L ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c 5226 Donald Bren Hall   (United States)

Author keywords

Interim analyses; Operating characteristics; Sample size; Stopping rules

Indexed keywords

ARTICLE; BAYES THEOREM; BIOSTATISTICS; CLINICAL RESEARCH; CONTROLLED STUDY; CRITERION VARIABLE; EXPERIMENTAL DESIGN; PRACTICE GUIDELINE; PROBABILITY; SEQUENTIAL ANALYSIS;

BAYES THEOREM; BIOMETRY; CLINICAL TRIALS DATA MONITORING COMMITTEES; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 36348967229     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2901     Document Type: Article

References (53)

1. Jennison C, Turnbull BW. Group Sequential Methods With Applications to Clinical Trials. CRC Press: Boca Raton, FL, 2000.
2. Whitehead J. The Design and Analysis of Sequential Clinical Trials. Wiley: New York, 1997.
3. Gillen DL, Emerson SS. Evaluating a group sequential design in the setting of nonproportional hazards. UW Biostatistics Working Paper Series. Working Paper 307, 2007. http://www.bepress.com/uwbiostat/ paper307
4. Emerson SS, Kittelson JM, Gillen DL. Bayesian evaluation of group sequential clinical trial designs. Statistics in Medicine 2007; 26:1431-1449.
5. Kittelson JM, Emerson SS. A unifying family of group sequential test designs. Biometrics 1999; 55:874-882.
6. Emerson SS, Banks PLC. Interpretation of a leukemia trial stopped early. Case Studies in Biometry. Wiley-Interscience: Somerset, NJ, 1994; 275-299.
7. Emerson SS. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach. Biometrics 1995; 51:1152-1162.
8. Jennison C, Turnbull BW. Statistical approaches to interim monitoring of medical trials: a review and commentary. Statistical Science 1990; 5:299-317.
9. Whitehead J. A unified theory for sequential clinical trials. Statistics in Medicine 1999; 18:2271-2286.
10. 0. The American Statistician 2000; 54(1):35-39.
11. Whitehead J, Stratton I. Group sequential clinical trials with triangular continuation regions (corr: V39, p. 1137). Biometrics 1983; 39:227-236.
12. Emerson SS, Fleming TR. Symmetric group sequential test designs. Biometrics 1989; 45:905-923.
13. Pampallona S, Tsiatis AA. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis. Journal of Statistical Planning and Inference 1994; 42:19-35.
14. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
15. Wang SK, Tsiatis AA. Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 1987; 43:193-199.
16. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-200.
17. Emerson SS. S + seqtrial technical overview. Technical Report, Insightful Corporation, Seattle, WA, 2003.
18. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
19. Pampallona S, Tsiatis AA, Kim KM. Spending functions for the type I and type II error probabilities of group sequential tests. Technical Report. Department of Biostatistics, Harvard University, 1995.
20. Chang MN, Hwang IK, Shih WJ. Group sequential designs using both type I and type II error probability spending functions. Communications in Statistics, Part A - Theory and Methods [Split from: Ψ(CommStat)] 1998; 27:1323-1339.
21. Pratt JW, Raiffa H, Schlaifer R. Introduction to Statistical Decision Theory. MIT Press: Cambridge, MA, 1995.
22. Lan KKG, Simon R, Halperin M. Stochastically curtailed tests in long-term clinical trials. Sequential Analysis 1982; 1:207-219.
23. Demets DL, Lan KKG. An overview of sequential methods and their application in clinical trials. Communications in Statistics, Part A - Theory and Methods [Split from: Ψ(CommStat)] 1984; 13:2315-2338.
24. Xiong X. A class of sequential conditional probability ratio tests. Journal of the American Statistical Association 1995; 90:1463-1473.
25. Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A, General 1969; 132:235-244.
26. Berry DA. A case for Bayesianism in clinical trials (Disc: p. 1395-1404). Statistics in Medicine 1993; 12: 1377-1393.
27. Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomized trials (Disc: p. 387-416). Journal of the Royal Statistical Society, Series A, General 1994; 157:357-387.
28. Emerson SS, Kittelson JM, Gillen DL. On the use of stochastic curtailment in group sequential clinical trials. UW Biostatistics Working Paper Series. Working Paper 243, 2005. http://www.bepress.com/uwbiostat/paper243
29. Emerson SS, Fleming TR. Parameter estimation following group sequential hypothesis testing. Biometrika 1990; 77:875-892.
30. The Cytel Software Corp. EaSt. The Cytel Software Corp.: Cambridge, MA, 2000.
31. PEST (Planning and Evaluation of Sequential Trials). The MPS Research Unit, The University of Reading, Reading, U.K., 2000.
32. Armitage P. Restricted sequential procedures. Biometrika 1957; 44:9-56.
33. Siegmund D. Estimation following sequential tests. Biometrika 1978; 65:341-350.
34. Fairbanks K, Madsen R. P values for tests using a repeated significance test design. Biometrika 1982; 69:69-74.
35. Jennison C, Turnbull BW. Confidence intervals for a binomial parameter following a multistage test with application to Mil-std 105d and medical trials. Technometrics 1983; 25:49-58.
36. Tsiatis AA, Rosner GL, Mehta CR. Exact confidence intervals following a group sequential test. Biometrics 1984; 40:797-803.
37. Kim K, Demets DL. Design and analysis of group sequential tests based on the type I error spending rate function. Biometrika 1987; 74:149-154.
38. Emerson SS. Statistical packages for group sequential methods. The American Statistician 1996; 50:183-192.
39. Duffy DE, Santner TJ. Confidence intervals for a binomial parameter based on multistage tests. Biometrics 1987; 43:81-93.
40. Chang MN, O'Brien PC. Confidence intervals following group sequential tests. Controlled Clinical Trials 1986; 7:18-26.
41. Rosner GL, Tsiatis AA. Exact confidence intervals following a group sequential trial: a comparison of methods. Biometrika 1988; 75:723-729.
42. Chang MN. Confidence intervals for a normal mean following a group sequential test. Biometrics 1989; 45: 247-254.
43. Chang MN, Gould AL, Snapinn SM. p-Values for group sequential testing. Biometrika 1995; 82:650-654.
44. Cook TD. p-Value adjustment in sequential clinical trials. Biometrics 2002; 58:1005-1011.
45. Gillen DL, Emerson SS. A note on P-values under group sequential testing and nonproportional hazards. Biometrics 2005; 61(2):546-551.
46. Whitehead J. On the bias of maximum likelihood estimation following a sequential test. Biometrika 1986; 73: 573-581.
47. Burington BE, Emerson SS. Flexible implementations of group sequential stopping rules using constrained boundaries. Biometrics 2003; 59:770-777.
48. S + SeqTrial. Insightful Corporation: Seattle, WA, 2002.
49. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51: 1315-1324.
50. Fisher LD. Self-designing clinical trials. Statistics in Medicine 1998; 17:1551-1562.
51. Tsiatis AA, Mehta CR. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika 2003; 90:367-378.
52. Gillen DL, Emerson SS. Information growth in a family of weighted logrank statistics under repeated analyses. Sequential Analysis 2005; 24(1):1-22.
53. Gillen DL, Emerson SS. Non-transitivity in a class of weighted logrank statistics under non-proportional hazards. Statistics and Probability Letters 2007; 77:123-130.